A STUDY TO CORRELATE THE SERUM URIC ACID LEVELS WITH THE DURATION AND SEVERITY OF MIGRAINE
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i12.46074Keywords:
headache, migraine, uric acid, migraine severityAbstract
Objectives: The objectives of the study were to assess the serum levels of uric acid in patients of migraine and to correlate the levels of uric acid with duration and severity of migraine.
Methods: This observational study was conducted in patients with complaint of headache, due to migraine who attended neurology and general medicine out patients department of tertiary care teaching hospital of Udaipur, Rajasthan. Uric acid levels were compared between both the genders with respect to age group, frequency of attack, and duration of migraine. Uric acid levels were also correlated with different parameters.
Results: A total of 500 patients were evaluated during the study period of 2 years. Mean uric acid in male patients was 5.02±1.40 mg/dl, and in females it was 4.99±1.39 mg/dl. Uric acid levels in male and female patients were found non-significant across all age groups, with duration of migraine and frequency of migraine attack (p>0.05). There was a significant correlation between uric acid levels and migraine severity in present study (p˂0.05), but there was no correlation with age, duration of migraine, and frequency of migraine attacks per month (p>0.05).
Conclusion: The study concluded that uric acid levels are within normal range in all age group as well as either of gender in patients of migraine. Hence, there is no relation between uric acid and duration and frequency of migraine but positive correlation with severity of migraine.
Downloads
References
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the international headache society. Cephalalgia 1988;8 Suppl 7:1-96.
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9. doi: 10.1212/01. wnl.0000252808.97649.21, PMID 17261680
Abu-arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: A systematic review of population-based studies. Dev Med Child Neurol 2010;52:1088-97. doi: 10.1111/j.1469-8749.2010.03793.x, PMID 20875042
Shaik MM, Gan SH. Vitamin supplementation as possible prophylactic treatment against migraine with aura and menstrual migraine. BioMed Res Int 2015;2015:469529. doi: 10.1155/2015/469529, PMID 25815319
Le H, Tfelt-Hansen P, Russell MB, Skytthe A, Kyvik KO, Olesen J. Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia 2011;31:43-64. doi: 10.1177/0333102410373159, PMID 20974590
Radat F, Kalaydjina A, Merikanjas KR. Psychiatric comorbidity in migraine. In: Schoenen J, Dodick DW, Sandor P, editors. Comorbidity in Migraine. London: Wiley-Blackwell; 2011. p. 1-13.
Togha M, Jahromi SR, Ghorbani Z, Martami F, Seifishahpar M. Serum Vitamin B12 and methylmalonic acid status in migraineurs: A case-control study. Headache 2019;59:1492-503. doi: 10.1111/head.13618, PMID 31471907
Celikbilek A, Gocmen AY, Zararsiz G, Tanik N, Ak H, Borekci E, et al. Serum levels of Vitamin D, Vitamin D-binding protein and Vitamin D receptor in migraine patients from central Anatolia region. Int J Clin Pract 2014;68:1272-7. doi: 10.1111/ijcp.12456, PMID 24837712
Wang L, Hu W, Wang J, Qian W, Xiao H. Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis. Mult Scler Relat Disord 2016;9:17-22. doi: 10.1016/j. msard.2016.05.008, PMID 27645338
Eren Y, Dirik E, Neşelioğlu S, Erel Ö. Oxidative stress and decreased thiol level in patients with migraine: Cross-sectional study. Acta Neurol Belg 2015;115:643-9. doi: 10.1007/s13760-015-0427-y, PMID 25595415
Yazar T, Yazar HO. Assessment of serum uric acid levels according to sex and stage for patients with Alzheimer-type dementia. Turk J Neurol 2019;25:76-81. doi: 10.4274/tnd.2019.85698
D’Amico D, Tepper SJ. Prophylaxis of migraine: General principles and patient acceptance. Neuropsychiatr Dis Treat 2008;4:1155-67. doi: 10.2147/ndt.s3497, PMID 19337456
Yazar T, Yazar HO, Aygün A, Karabacak V, Altunkaynak Y, Kirbaş D. Evaluation of serum uric levels in migraine. Neurol Sci 2021;42:705-9. doi: 10.1007/s10072-020-04598-w, PMID 32691177
Hong P, Liu Y, Wan Y, Xiong H, Xu Y. An exponential curve relationship between serum urate and migraine: A cross-section study from NHANES. Front Neurol 2022;13:871783. doi: 10.3389/ fneur.2022.871783, PMID 35493816
Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: The role of hormones and their impact on vascular diseases. J Headache Pain 2012;13:177-89. doi: 10.1007/s10194-012-0424-y, PMID 22367631
Tekeşin A, Tunç A. Evaluation of inflammatory markers in patients with migraine. Arch Clin Exp Med 2019;4:37-40. doi: 10.25000/ acem.494415
Koçer A, Dikici S, Atakay S, Okuyucu S. Serum uric acid and lipid levels while taking topiramate for migraine. Headache 2008;48:1056-60. doi: 10.1111/j.1526-4610.2007.01008.x, PMID 18179568
Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C. Gender-related differences in migraine. Neurol Sci 2020;41(Suppl 2):429-36. doi: 10.1007/s10072-020-04643-8, PMID 32845494
Delaruelle Z, Ivanova TA, Khan S, Negro A, Ornello R, Raffaelli B, et al. Male and female sex hormones in primary headaches. J Headache Pain 2018;19:117. doi: 10.1186/s10194-018- 0922-7, PMID 30497379
Schroeder RA, Brandes J, Buse DC, Calhoun A, Eikermann-Haerter K, Golden K, et al. Sex and gender differences in migraine-evaluating knowledge gaps. J Womens Health (Larchmt) 2018;27:965-73. doi: 10.1089/jwh.2018.7274, PMID 30129895
Trauninger A, Leél-Ossy E, Kamson DO, Pótó L, Aradi M, Kövér F, et al. Risk factors of migraine-related brain white matter hyperintensities: An investigation of 186 patients. J Headache Pain 2011;12:97-103. doi: 10.1007/s10194-011-0299-3, PMID 21331756
Published
How to Cite
Issue
Section
Copyright (c) 2022 Renu Khamesra, Akshay Panchal
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
